We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Webinars

Expo ADLM Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Webinars Advertise with Us

PURITAN MEDICAL

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products:

Cytology Collection Solution

Lipoprotein (a) Blood Test

Mobile Critical Care Blood, Gas & Electrolytes Analyzer

SARS-CoV-2 Antigen Test

SARS-CoV-2 & Influenza A/B Test

More products

GLOBE SCIENTIFIC, LLC

DIASYS DIAGNOSTIC SYSTEMS

Download Mobile App

Featured Video

ADLM:
ADLM 2025 – Bring the wonder to the premier global laboratory medicine conference

Q&A with ADLM 2025 Annual Meeting Organizing Committee Chair

Practical Approaches to Measuring and Interpreting Alzheimer’s Disease Biomarkers

Using ChatGPT Prompts to Enhance Clinical Data Analysis Through Coding

ADLM 2025 Plenaries to Cover the Latest in Lab Medicine

Fully Automated HbA1c Analyzer Available for Inspection at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016

A fully automated, high-throughput system for HbA1c testing will be available for inspection at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

Roche (Basel, Switzerland) will introduce the cobas c 513 analyzer at Booth 1301 of the Philadelphia expo. More...

The c 513 is a fully automated, high-throughput HbA1c testing solution with a module that can reach a throughput of up to 400 determinations per hour. The reagent compartment has 60 reagent positions that can be loaded providing up to 14,000 results.

The instrument features direct results reporting, which minimizes the risk of result misinterpretation and eliminates the need for performing time-consuming, manual result interpretation. This new analyzer also offers closed tube sampling, which reduces hands-on time, prevents sample contamination, and ensures operator safety.

As the instrument is still awaiting FDA 510(k) approval, the c 513 is not currently available in the USA.

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Roche

Visit expo >

New

Gold Member

Quality Control Material

iPLEX Pro Exome QC Panel

Serological Pipet Controller
PIPETBOY GENIUS

New

Gold Member

Serological Pipets

INTEGRA Serological Pipets

New

Specimen Radiography System

TrueView 200 Pro

Read the full article by registering today, it's FREE!

It's Free!

Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.

Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine (available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every week containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!

Sign in: Registered website members

Sign in: Registered magazine subscribers

DIASOURCE (A Biovendor Company)

Latest AACC 2016 News

Channels

Clinical Chemistry

view channel

Image: Skin swabs could detect Parkinson’s disease up to seven years before symptoms appear (Photo courtesy of The University of Manchester)

Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear

Parkinson’s disease is notoriously difficult to diagnose in its early stages, as motor symptoms do not appear until later in the progression of the disease. The ability to detect the disease up to seven... Read more

New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs

A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more

Image: The new research involved using digital PCR as a reference method to standardize test results between laboratories (Photo courtesy of Adobe Stock)

New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results

Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more

Image: A pen-like tool collects molecules from the skin that can be screened for opioids (Photo courtesy of William Clarke/Johns Hopkins)

Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin

Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read more

Molecular Diagnostics

view channel

Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

New Gene Tool to Enable Earlier Detection and Treatment of Cardiometabolic Diseases

Cardiometabolic diseases, which affect the heart, blood vessels, and the body's ability to process food and generate energy, are difficult to diagnose early due to the complex genetic changes that contribute... Read more

Image: Pathway-specific polygenic scores can predict individual responses to lithium treatment for bipolar disorder (Photo courtesy of Shutterstock)

Genetic Tool Predicts Lithium Responsiveness in Bipolar Disorder Patients

Bipolar disorder (BD) is characterized by cycles of extreme low and high moods. Lithium has long been the gold standard in treating BD since its mood-stabilizing properties were discovered in 1949.... Read more

Hematology

view channel

Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Image: The FINDER multifunctional testing platform can run multiple types of tests and deliver rapid results for near-patient use (Photo courtesy of Baebies)

First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more

Image: The 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia (Photo courtesy of 123RF)

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Immunology

view channel

Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Microbiology

view channel

Image: Researchers have identified a metabolite produced by gut bacteria as a driver of atherosclerosis (Photo courtesy of CNIC)

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis

Cardiovascular disease is the leading cause of death worldwide, and atherosclerosis plays a critical role in its development. This chronic condition, characterized by the hardening and narrowing of arteries... Read more

Image: Using viral load tests can help predict mpox severity when skin lesions first appear (Photo courtesy of Laiman Kana Ariga/Nagoya University)

Viral Load Tests Can Help Predict Mpox Severity

Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more

Image: Gut microbiota dysbiosis has been linked to the onset and progression of gestational diabetes (Photo courtesy of 123RF)

Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes

Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read more

Image: The new handheld TB testing device significantly improves disease detection in HIV patients (Photo courtesy of Vincent Postle/Tulane University)

Credit Card-Sized Test Boosts TB Detection in HIV Hotspots

Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more

Pathology

view channel

AI-Powered Biomarker System Redefines Thyroid Cancer Progression and Subtypes

Differentiated thyroid carcinoma (DTC) is typically indolent, and some patients can be managed without immediate surgery. However, it remains a significant clinical challenge to determine which patients... Read more

Image: Schematic of the methodology combining MEA, EIS and ML to non-invasively monitor cell spatiotemporal dynamics (Yagüe et al., Science Advances, DOI: 10.1126/sciadv.adx4919)

Innovative Technology Successfully Monitors Cancer Progression

Tracking the progression of cancer and understanding how cancer cells behave over time remains a significant challenge in oncology. Live-cell fluorescence microscopy is currently the predominant method... Read more

image: BiGraph links local cell patterns to patient survival outcomes, offering interpretable insights into cancer prognosis (Wang, Z. et al., Patterns (2025); doi.org/10.1016/j.patter.2025.101178)

AI Tool Accurately Determines Breast Cancer Prognosis

A new study has found that cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to treatment. The research, published in the journal Patterns,... Read more

image: The new tool called OmicsTweezer uses advanced machine learning techniques to analyze large-scale biological data (Yang, et al., Cell Genomics, 2025; doi.org/10.1016/j.xgen.2025.100950)

Powerful New Tool Improves Tissue Cancer Analysis

Studying the mix of cell types in human tissue is crucial for understanding diseases like cancer, but it presents significant challenges in both accuracy and scalability. The tumor microenvironment, composed... Read more

Technology

view channel

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more

Image: Student researcher Liyan Ming, first author of the study, setting up a fluorescence imaging experiment (Photo courtesy of Riccardo Marin)

Safer, Portable and Low-Cost Imaging Solution to Revolutionize Biomedical Diagnostics

In diagnosing diseases and monitoring treatment, accurate and quick detection of temperature within biological tissues can be crucial, especially in early disease detection. Conventional methods such as... Read more

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more

Image: Illustration of the high-sensitivity detection of trace amounts of cancer DNA in blood and its analysis using an AI-based method (Photo courtesy of KIMS)

Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis

Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read more

Industry

view channel

Image: The FebriDx rapid POC test uses a ﬁngerstick blood sample to aid in the diﬀerentiation between bacterial and viral infection (Photo courtesy of Lumos Diagnostics)

PHASE Scientific and Lumos Diagnostics Partner on Rapid POC Test for Bacterial Respiratory Infection

A critical gap exists in the diagnosis of respiratory infections, which are often difficult to distinguish quickly and accurately as either bacterial or non-bacterial in origin. This challenge has led... Read more

Image: The fCAL turbo and fPELA turbo assays will be available on the VITROS Systems as an MPA (Photo courtesy of QuidelOrtho)

QuidelOrtho and BÜHLMANN Collaborate on Gastrointestinal Biomarker Tests

QuidelOrtho Corporation (San Diego, CA, USA) and BÜHLMANN Laboratories AG (Schönenbuch, Switzerland) have announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's... Read more

Image: The combined company will have best-in-class liquid chromatography, mass spectrometry, flow cytometry, and diagnostic solutions

BD Biosciences & Diagnostic Solutions to Merge with Waters

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Waters Corporation (Milford, MA, USA) have entered into a definitive agreement to combine BD's Biosciences & Diagnostic Solutions... Read more

Image: Whether as a webinar or forum at the trade fair, the accompanying program at COMPAMED is always in high demand (Photo courtesy of Constanze Tillmann)

2025 COMPAMED Innovation Forum Highlights Pioneering Work in Cancer Diagnostics

Cancer cases are among the biggest challenges faced by global healthcare systems. The incidence has risen in recent decades, not least on account of demographic change and escalating risk factors.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2025
MEDLAB 2024
Medica Medlab 2023
Medica EUROMEDLAB Medlab

2022
MEDICA ECCMID EUROMEDLAB Medlab 2021
Medica MEDLAB COV 2020
MEDLAB

Copyright © 2000-2025 Globetech Media. All rights reserved.

MOBILE | FULL SITE